These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20864652)

  • 1. Analysis of differentially expressed genes in LNCaP prostate cancer progression model.
    Xie BX; Zhang H; Wang J; Pang B; Wu RQ; Qian XL; Yu L; Li SH; Shi QG; Huang CF; Zhou JG
    J Androl; 2011; 32(2):170-82. PubMed ID: 20864652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
    Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
    Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
    Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model.
    Balaji KC; Rao PS; Smith DJ; Louis S; Smith LM; Sherman S; Bacich D; O'Keefe D
    Urol Oncol; 2004; 22(4):313-20. PubMed ID: 15283889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.
    Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS
    Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
    Freedland SJ; Pantuck AJ; Paik SH; Zisman A; Graeber TG; Eisenberg D; McBride WH; Nguyen D; Tso CL; Belldegrun AS
    Prostate; 2003 Jun; 55(4):299-307. PubMed ID: 12712409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
    Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
    J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR2 expression correlates with prostate cancer progression.
    Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
    J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
    Giménez-Bonafé P; Fedoruk MN; Whitmore TG; Akbari M; Ralph JL; Ettinger S; Gleave ME; Nelson CC
    Prostate; 2004 May; 59(3):337-49. PubMed ID: 15042610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells.
    Ngan S; Stronach EA; Photiou A; Waxman J; Ali S; Buluwela L
    Oncogene; 2009 May; 28(19):2051-63. PubMed ID: 19363526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genes expressed differentially by LNCaP or PC-3 prostate cancer cell lines.
    Yang M; Loda M; Sytkowski AJ
    Cancer Res; 1998 Aug; 58(16):3732-5. PubMed ID: 9721886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K; Uemura H; Ishiguro H; Kubota Y
    Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen.
    Coutinho-Camillo CM; Salaorni S; Sarkis AS; Nagai MA
    Cancer Genet Cytogenet; 2006 Apr; 166(2):130-8. PubMed ID: 16631469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
    Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
    Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
    Herness EA; Naz RK
    Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
    Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
    Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.